Pacs (PACS) Cash & Equivalents (2023 - 2026)

Pacs' Cash & Equivalents history runs 4 years deep, the most recent figure standing at $248.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 13.75% year-over-year to $248.0 million; the TTM figure through Mar 2026 stood at $248.0 million (down 13.75% YoY), while the FY2025 annual figure was $197.0 million, up 24.95% from the prior year.
• Cash & Equivalents came in at $248.0 million for Q1 2026 at Pacs, up from $197.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $355.7 million in Q3 2025 to a low of $38.2 million in Q2 2023.
• A 4-year average of $155.3 million and a median of $94.3 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents decreased 28.33% in 2024 and jumped 618.25% in 2025, its largest moves.
• Pacs' Cash & Equivalents stood at $73.4 million in 2023, then surged by 114.77% to $157.7 million in 2024, then climbed by 24.95% to $197.0 million in 2025, then gained by 25.87% to $248.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $248.0 million, $197.0 million, and $355.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison